<code id='4061F0A63B'></code><style id='4061F0A63B'></style>
    • <acronym id='4061F0A63B'></acronym>
      <center id='4061F0A63B'><center id='4061F0A63B'><tfoot id='4061F0A63B'></tfoot></center><abbr id='4061F0A63B'><dir id='4061F0A63B'><tfoot id='4061F0A63B'></tfoot><noframes id='4061F0A63B'>

    • <optgroup id='4061F0A63B'><strike id='4061F0A63B'><sup id='4061F0A63B'></sup></strike><code id='4061F0A63B'></code></optgroup>
        1. <b id='4061F0A63B'><label id='4061F0A63B'><select id='4061F0A63B'><dt id='4061F0A63B'><span id='4061F0A63B'></span></dt></select></label></b><u id='4061F0A63B'></u>
          <i id='4061F0A63B'><strike id='4061F0A63B'><tt id='4061F0A63B'><pre id='4061F0A63B'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:32259
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Bacterial infection may be ‘key event’ in endometriosis, study says
          Bacterial infection may be ‘key event’ in endometriosis, study says

          AnewstudydocumentshowFusobacteriummightspurthedevelopmentofendometriosis.V.R.Dowell/CDCEndometriosis

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Meta looks to target Twitter with a rival app called Threads

          Theannouncementofthesocialmediaapp'Threads'isdisplayedinApple'sUSAppStoreseenonthescreenofasmartphon